Bering Capital

Transforming Healthcare

Developing the early DNA of business through trust and culture

Navigating innovative business with early strategic insights

Reliable expertise in a volatile world

Creating a new world with fundamentally strong companies

Passionate about the future, visionary in how to build it

We believe in the primacy of great markets and great people all aligned with one mission

About Us

Seasoned partners in navigating varied stages of growth

People

We help build great companies with inspiration and support

Companies

Latest News

View All

12.03.2024

Coherus sells its last biosimilar Udenyca to Intas for up to $558M as company homes in on novel cancer meds

06.27.2024

CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

03.11.2024

Cellworks Personalized Therapy Biosimulation Study Produces Superior OS and DFS Predictions for Gastroesophageal Cancer Patients

02.28.2024

CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference